Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 12:00 PM
Ignite Modification Date:
2025-12-24 @ 12:00 PM
NCT ID:
NCT05734261
Eligibility Criteria:
Inclusion Criteria:
* Age between 6 and 16 years
* FEV1 \> 60%
* Child referred to the pulmonary function test laboratory for a non-specific bronchial hyperactivity test with methacholine
* Child under treatment with inhaled corticosteroids stopped for at least 3 weeks
* Oral consent from the child and at least one of the legal representatives
* Child affiliated or benefiting from a social security plan
Exclusion Criteria:
* Use of a short-acting beta-adrenergic bronchodilator within the last 6 hours or anticholinergic bronchodilator within the last 12 hours
* Use of a long-acting beta-adrenergic bronchodilator (licensed for use in children) in the past 36 hours
* Upper or lower respiratory tract infections within 3 weeks prior to inclusion
* Epilepsy under treatment
* Subject's participation in another interventional study that may alter respiratory function
* Patient unable to give consent, vulnerable
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
6 Years
Maximum Age:
16 Years
Study:
NCT05734261
Study Brief:
Protocol Section:
NCT05734261